Hainan Haiyao Stock Hits Day Low of CNY 5.23 Amid Price Pressure

Hainan Haiyao Co., Ltd., a mid-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable decline today, with its stock price dropping by 5.24% as of March 20, 2026. The stock reached an intraday low of CNY 5.23, reflecting ongoing challenges faced by the company. Over the past week, Hainan Haiyao has seen a decrease of 7.58%, and its performance over the last month has been even more pronounced, with a decline of 15.62%. Year-to-date, the stock has fallen by 26.71%, significantly underperforming the China Shanghai Composite, which has only dipped by 0.3% during the same period. Financial metrics indicate that Hainan Haiyao has been grappling with operational difficulties, as evidenced by a negative trend in net sales, which have decreased at an annual rate of 17.71% over the last five years. The company has reported operating losses and has faced high debt levels, with a debt-to-equity ratio of 8.89. Additionally, the stock has underperformed the market over the past year, generating a return of just 4.38% compared to the China Shanghai Composite's 16.08%.